miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
Carcinogenesis, 08/01/2012
Zhu DX et al. – The results suggest that miR–181a/b may play important roles in the pathogenesis of chronic lymphocytic leukemia (CLL) and may provide a possible therapeutic avenue and a sensitive indicator of the activity of the p53 axis in CLL.



